|Bid||260.22 x 800|
|Ask||260.17 x 1300|
|Day's range||257.56 - 261.55|
|52-week range||154.88 - 279.33|
|Beta (5Y monthly)||1.05|
|PE ratio (TTM)||74.05|
|Earnings date||12 Feb 2024 - 16 Feb 2024|
|Forward dividend & yield||N/A (N/A)|
|1y target est||276.21|
SANTA FE, N.M., December 07, 2023--Cadence Molecular Sciences (OpenEye) will provide molecular design software to power NIH-funded antiviral discovery consortium's research efforts.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
The fact that multiple Cadence Design Systems, Inc. ( NASDAQ:CDNS ) insiders offloaded a considerable amount of shares...